Trocade

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2001-2016
01220012016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Patients with rheumatoid arthritis (RA) have benefited from an unprecedented treatment improvement over the last two decades… (More)
Is this relevant?
2014
2014
Pneumococcal meningitis (PM) results in high mortality rates and long-lasting neurological deficits. Hippocampal apoptosis and… (More)
Is this relevant?
2006
2006
The structural features contributing to the different pharmacokinetic properties of the TACE/MMP inhibitors TNF484 and Trocade… (More)
Is this relevant?
2005
2005
FR255031 (2-[(7S)-7-[5-(4-ethylphenyl)-2-thienyl]-1,1-dioxido-4-(2-pyridinylcarbonyl)hexahydro-1,4-thiazepin-7-yl]-N… (More)
Is this relevant?
2002
2002
A new series of succinate-based dual inhibitors against matrix metalloproteinases (MMPs) and tumor necrosis factor alpha… (More)
Is this relevant?
2002
2002
Rheumatoid arthritis (RA) is a common cause of disability and deformity for which treatment is often of limited value in… (More)
  • table 2
Is this relevant?
2002
2002
Rheumatoid arthritis (RA) is a common cause of disability and deformity for which treatment is often of limited value in… (More)
  • table 2
Is this relevant?
2001
2001
OBJECTIVES The purpose of this study was to assess the tolerability and multiple-dose pharmacokinetics of Trocade in rheumatoid… (More)
Is this relevant?
Review
2001
Review
2001
The rheumatic diseases continue to represent a significant healthcare burden in the 21st century. However, despite the best… (More)
  • table 1
  • table 2
  • figure 1
Is this relevant?